Charles W. Bolten

A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity

Jessica D. Dietz, Sarah Du, Charles W. Bolten et al. · Hypertension · 2008 · 125 citations · Full text

Medicine, Cardiology, Pharmacology +13

Induction of Human Liver X Receptor α Gene Expression Via an Autoregulatory Loop Mechanism

Yu Li, Charles W. Bolten, Balkrishen Bhat et al. · Molecular Endocrinology · 2002 · 97 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances.

Sebastian Kevekordes, Jeanine C. Spielberger, Christian M Burghaus et al. · PubMed · 2001 · 87 citations

Pharmacy, Pharmacology, Toxicology +10

Insulin sensitizing pharmacology of thiazolidinediones correlates with mitochondrial gene expression rather than activation of PPAR gamma.

Charles W. Bolten, Patrick M. Blanner, William Graham McDonald et al. · PubMed · 2007 · 38 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Discovery of 3-Cyano- <i>N</i> -(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 <i>H</i> -pyrrolo[2,3- <i>b</i> ]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist

Mark E. Schnute, Mattias Wennerstål, Jennifer Alley et al. · Journal of Medicinal Chemistry · 2018 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17